title: Proposal To Use VA Price As a Benchmark Is off the Mark.
abstract: While the politics of tapping into anger about high drug prices would seem to have made Proposition 61 an easy sell, the initiative actually had a lot going against it. The pharmaceutical industry didn't take it lightly, raising over $100 million to defeat it.
authors.forename: Richard Mark
authors.initials: RM
authors.lastname: Kirkner
mesh_terms: D019985:Benchmarking; D002140:California; D016527:Drug Costs / Q000331:legislation & jurisprudence* / Q000639:trends*; D004345:Drug Industry / Q000191:economics*; D017850:Economics, Pharmaceutical / Q000331:legislation & jurisprudence* / Q000639:trends*; D005544:Forecasting; D033161:Government Regulation; D018166:Health Care Reform; D006801:Humans; D011057:Politics; D014481:United States